knowledge -WSS

knowledge

author：entertainment 2025-08-31 01:57:06 - browse：3669

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： White House drug shortage group privately met with industry

WSS

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Humana, CVS hope to turn members into patients at clinics

Anthony Fauci pushes back on GOP claims during Covid hearing

ER docs worry over extreme heat as a 'mass casualty event'

Humana, CVS hope to turn members into patients at clinics

knowledge

knowledge

focus

Drug repurposing or repositioning? The language matters

Fight over Supreme Court dialysis ruling puts kidney patients at risk

At least 13 dead in Texas as scorching temps continue

Humana, CVS hope to turn members into patients at clinics

As demand for Covid shots wanes, Moderna seeks its next success

Humana, CVS hope to turn members into patients at clinics

The high cost of giving birth even with insurance

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Activists slam private health insurers over coverage restrictions

An outdated Medicare rule harms dementia patients with anxiety

explore

ProMED, early warning system on disease outbreaks, in peril

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Elevance PBM president out as customers face prescription chaos

ProMED, early warning system on disease outbreaks, in peril

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

entertainment

explore

entertainment

explore